Personalized Stimulation Loop for Neurorehabilitation in Parkinson: a Proof-of-principle Study

Recruiting N/A Interventional Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
University of Zurich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Parkinson's disease (PD) is a neurodegenerative disease that affects about 1% of the elderly population and accounts for substantial disability and health care costs. Disability is largely driven by mobility deficits caused by impaired gait. Effective treatments are available to restore lower limb function and improve gait, but response to treatment varies greatly from patient to patient and often…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Idiopathic Parkinson's disease with gait and postural stability deficits * ≥18 years of age * UPDRS III gait scores 1-3 * UPDRS III postural instability scores 1-3 * Prescribed rehabilitation therapy * Informed consent as documented by signature * Adjustments in dopaminergic m…
Contacts

Christian Baumann, Prof. Dr. med.

+41 44 255 00 02

christian.baumann@usz.ch

CONTACT

Angelina Maric, Dr. phil.

+ 41 255 86 15

angelina.maric@usz.ch

CONTACT